Our Mission

Taiho Oncology, Inc. works urgently to discover and develop innovative cancer treatments. As cancer evolves, we evolve with it—bringing novel technology to cornerstone chemotherapies, while at the same time optimizing new targeted agents. Advanced technology, dedicated investigators, and incomparable facilities—these vast resources empower us to redefine the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.

Taiho Oncology, Inc. works urgently to discover and develop innovative cancer treatments. As cancer evolves, we evolve with it—bringing novel technology to cornerstone chemotherapies, while at the same time optimizing new targeted agents. Advanced technology, dedicated investigators, and incomparable facilities—these vast resources empower us to redefine the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.

Challenging Cancer Is Our Legacy

Born from Taiho Pharmaceutical’s legacy of developing and marketing leading anti-metabolite cancer drugs, Taiho Oncology is focused on smarter cornerstone anti-metabolites as well as on targeted small molecule inhibitors.

Taiho Pharmaceutical engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy/immunology, and urology. The company also offers nutrient tonic and crude drug gastrointestinal remedy products.

ONCOLOGY

Since releasing Futraful (tegafur) in 1974, Taiho Pharmaceutical has been a pioneer in the field of oral anti-cancer agents with products including UFT (tegafur uracil) and TS-1 Capsules (tegafur, gimeracil, oteracil potassium).

ALLERGY/IMMUNOLOGY

Leveraging its findings during the development of IPD (suplatast tosilate), Taiho Pharmaceutical has begun developing anti-allergic drugs with new mechanisms of action.

UROLOGY

Based on the development of BUP-4 (propiverine hydrochloride), Taiho Pharmaceutical is proceeding with research and development in new types of treatments for urinary incontinence.

A Member of Otsuka Holdings

As a member of the Otsuka Group, Taiho Oncology, Inc. is part of a group of over 150 companies that are dedicated to improving global health and well-being. Together, we have a long history of providing comprehensive healthcare solutions, ranging from diagnosis to the treatment of disease.

For more information, visit www.otsuka.com/en.

Our Corporate Identity

Taiho Oncology's corporate identity was designed to reflect the organization’s guiding principles and to inspire feelings of natural energy, vitality, youth, and vigor.

The Symbol

The main concept of the Taiho Oncology logo is that of vital energy, with an emphasis on the energy produced by Mother Nature. This refers to the natural energy that puts forth a tree, which then grows a robust trunk, extends a branch, makes a flower bloom, and then bears fruit. The logo also captures the harmony between earth and sun—the source of all growth and vitality on earth. This is a symbol of vitality from ancient times.

The “T” represents the initial letter of Taiho, and the power of nature is expressed by the fact that the logo is hand drawn.

The Colors

Red is used to portray our company’s energy, vitality, and liveliness. The sepia (brown), an ecological color, represents human beings on earth and an intention of natural symbiosis. The yellow conveys that this is a new company, overflowing with youth and vigor.

Success!

Job description sent to

Success!

Event sent to

Success!

News Release sent to